Basic Science News at Duke School of Medicine

A proposed cap on National Institutes of Health funding could cost Duke University millions and stall critical breakthroughs -- like Laurie Sanders's blood test for early Parkinson's disease.

Cigarette and other tobacco smoking are responsible for millions of deaths worldwide each year. Nicotine drives addiction to tobacco, and the brain’s reaction to it is complex.

Annual DARE Awards were presented for groundbreaking research in cancer, neuroscience, cell biology and biochemistry.

Data reveal a new era of lung cancer surgery—less invasive, more precise, and still life-saving.

In recognition of Women's History Month, the School of Medicine highlights just a handful of the women making an impact in the basic sciences.

This discussion delves into the groundbreaking research being conducted at Duke University and its profound implications for public health.

Duke University School of Medicine’s research symposium showcased how discovery science, AI, technology, and translation are driving progress on some of the biggest challenges in biomedical science.

Hidden sweeteners in oral nicotine pouches mask the sting of nicotine but may entice first-time users and youth consumption. 

Duke University School of Medicine researchers reveal how fungi can be both a species-threatening force and a vital part of our ecosystem. From recycling nutrients and trapping carbon to making bread rise and producing antibiotics, fungi are indispensable.

Dr. Raphael Valdivia, the Nanaline H. Duke Distinguished Professor of Molecular Genetics and Microbiology, emphasizes the need to understand the human immune system to address diseases like cancer and neurodegenerative disorders. His research focuses on leveraging AI and genetic engineering to guide immunity, highlighting Duke's strengths in transplant immunology and infectious disease research.